• 1
    Bryan CF, Nelson PW, Shield CF 3rd et al. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. In: CeckaJM, TerasakiPI, eds. Clinical Transplants 2004 Los Angeles , CA : UCLA Tissue Typing Laboratory; 2004; 127133.
  • 2
    Sorensen JB, Grant WJ, Belnap LP, Stinson J, Fuller TC. Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am J Transplant 2001; 1: 296299.
  • 3
    Nelson PW, Shield CF 3rd, Muruve NA et al. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: Time for a new national system? Am J Transplant 2002; 2: 9499.
  • 4
  • 5
    Department of Health and Human Services; Health Resources and Services Administration. Organ Procurement and Transplantation Network Status of Living Donor Guidelines. Federal Register, Monday, January 23, 2006; 71: 35193520.
  • 6
    Magee CC. Transplantation across previously incompatible immunological barriers. Transplant Int 2006; 19: 8797.
  • 7
    Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch: A single center's perspective. Pediatr Transplant 2004; 8: 535542.
  • 8
    Punch JD, Hayes DH, LaPorte F, McBride V, Seely MS. Organ donation and utilization in the United States, 1996–2005. Am J Transplant 2007; 7: 1327–1338.
  • 9
    Scientific Registry of Transplant Recipients, Final Analysis for Data Request from the OPTN Organ Availability, OPO and Kidney Committees Meeting of April 28, 2006.
  • 10
    Ashby VB, Lin M, Kalbfleisch JD, Port FK, Wolfe RA, Leichtman AL. Geographic variability in access to kidney transplantation in the United States, 1996–2005. Am J Transplant 2007; 7: 14121423.
  • 11
    Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783790.
  • 12
    Sung RS, Guidinger MK, Lake C et al. Impact of the expanded criteria donor kidney allocation system on the use of expanded criteria donor kidneys. Transplantation 2005; 79: 12571261.
  • 13
    Machicao VI, Srinivas TR, Hemming AW et al. Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation. Liver Transpl 2006; 12: 754761.
  • 14
    Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int 2005; 68: 362370.
  • 15
    Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235242.
  • 16
    Hornberger JC, Best JH, Garrison LP Jr. Cost-effectiveness of repeat medical procedures: Kidney transplantation as an example. Med Decis Making 1997; 17: 363372.
  • 17
    Sutherland DE, Cecka M, Gruessner AC. Report from the International Pancreas Transplant Registry—1998. Transplant Proc 1999; 31: 597601.
  • 18
    Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004; 4: 20182026.
  • 19
    Ojo AO, Meier-Kriesche HU, Hanson JA et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 8290.
  • 20
    Rayhill SC, D'Alessandro AM, Odorico JS et al. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: Is there a difference in survival? Ann Surg 2000; 231: 417423.
  • 21
    Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290: 28172823.